The US National Kidney Foundation did not recommend routine administration of L-carnitine to subjects undergoing dialysis yet encouraged the development of trials in patients with select symptoms that do not respond to standard therapy, i.e., persistent muscle cramps or hypotension during dialysis, severe fatigue, skeletal muscle weakness or myopathy, cardiomyopathy, and anemia requiring large doses of erythropoietin (74, 75)
Das sieht man zum Beispiel bei chronischen Entzndungen, Rauchen, hoher Umweltbelastung, intensivem Sport, Leberbelastung, Diabetes, Alterungsprozessen oder mitochondrialem Stress
The Group 2 samples were included in order to assess the concordance between both Abbott assays (GT II and GT Plus )
Wang M, Dai M, Wang D, Tang T, Xiong F, Xiang B, et al